Plain-English translation of NCT00662090 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is trying to better understand two rare blood disorders that affect children and teenagers: myelodysplastic syndromes (a condition where the bone marrow doesn't make healthy blood cells) and juvenile myelomonocytic leukemia (a type of blood cancer). Researchers will use advanced genetic testing to look at blood and bone marrow samples to find patterns that help doctors diagnose these conditions more accurately and understand how different patients respond to treatment.
Right now, doctors sometimes struggle to correctly diagnose and classify these rare childhood blood disorders because the genetic changes involved can be subtle and complex. By studying a large group of children with these conditions, researchers hope to create a clearer picture of what these diseases look like genetically, which could help doctors diagnose them faster and choose better treatments.
You likely qualify if…
You likely don't qualify if…
If you participate, you would allow researchers to study your existing bone marrow and blood samples using advanced genetic testing techniques. Your medical records and information about your diagnosis, treatment, and health outcomes would also be reviewed as part of the study. You would be followed over time so researchers can track how you respond to treatment and gather information that helps them understand these diseases better.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Germany